The board of Nyfosa AB (“Nyfosa”) has resolved to utilize the authorization regarding the acquisition of its own shares granted by Nyfosa’s Annual General Meeting held on 6 May 2025. The purpose of acquiring own shares is to adjust the company’s capital structure, thereby efficiently contributing to an increase in shareholder value. Over time, own shares may be transferred as payment, or in order to finance acquisitions of real property or real property companies, or in order to finance investments in real properties.

Acquisitions of own shares may take place in accordance with Nasdaq Stockholm’s Rulebook for Issuers of Shares, on one or more occasions during the period up until Nyfosa’s Annual General Meeting 2026. Nyfosa's holding of own shares following acquisitions may pursuant to the resolution by the Annual General Meeting at no point in time exceed 10% of all of the shares in Nyfosa. Repurchase of Nyfosa’s own shares shall be made on Nasdaq Stockholm at a price within the price range for the share price prevailing at any time (the so-called spread), and in accordance with the rules relating to price set out in Nasdaq Stockholm's Rulebook for issuers. Payment for the shares shall be made in cash.

DNB Carnegie Investment Bank AB has been appointed as Nyfosa’s advisor in relation to the repurchase of shares.

At the time of this press release, the total number of shares in Nyfosa amounts to 208,106,276, all of which are ordinary shares of Class A.